Table 3.
Comorbidities of the patients enrolled in the study.
| Comorbidities | Total Patients n (%) | * CAPA Patients n (%) | * Aspergillus Colonisation Patients n (%) |
|---|---|---|---|
| Cardiovascular system | |||
| Arterial hypertension | 20/43 (46.5) | 15/43 (34.9) | 5/43 (11.6) |
| Atrial fibrillation | 3/43 (7.0) | 3/43 (7.0) | |
| Coronary angioplasty | 1/43 (2.3) | 1/43 (2.3) | |
| Coronary disease | 5/43 (11.6) | 4/43 (9.3) | 1/43 (2.3) |
| Heart attack history | 5/43 (11.6) | 4/43 (9.3) | 1/43 (2.3) |
| Heart failure | 1/43 (2.3) | 1/43 (2.3) | |
| Giant cell arthritis | 1/43 (2.3) | 1/43 (2.3) | |
| Venous thrombosis | 3/43 (7.0) | 3/43 (7.0) | |
| Respiratory system | |||
| Bronchial asthma | 3/43 (7.0) | 2/43 (4.7) | 1/43 (2.3) |
| Emphysema | 1/43 (2.3) | 1/43 (2.3) | |
| Obstructive sleep apnoea | 2/43 (4.7) | 1/43 (2.3) | 1/43 (2.3) |
| Pulmonary embolism | 1/43 (2.3) | 1/43 (2.3) | |
| Chronic obstructive pulmonary disease | 2/43 (4.7) | 1/43 (2.3) | 1/43 (2.3) |
| Haematological/Ontological malignancies | |||
| Chronic lymphocytic leukaemia | 3/43 (7.0) | 1/43 (2.3) | 2/43 (4.7) |
| Multiple myeloma | 2/43 (4.7) | 1/43 (2.3) | 1/43 (2.3) |
| Malignancy | 1/43 (2.3) | 1/43 (2.3) | |
| Red blood cells dysplasia | 1/43 (2.3) | 1/43 (2.3) | |
| Spinal cord ependymoma | 1/43 (2.3) | 1/43 (2.3) | |
| Kidney diseases | |||
| Chronic renal failure | 1/43 (2.3) | 1/43 (2.3) | |
| Disorders of endocrine glands | |||
| Diabetes mellitus | 13/43 (30.2) | 8/43 (18.6) | 5/43 (11.6) |
| Hypothyroidism | 4/43 (9.3) | 2/43 (4.7) | 2/43 (4.7) |
| Dyslipidaemia | 13/43 (30.2) | 12/43 (27.9) | 1/43 (2.3) |
| Other diseases | |||
| HBV carrier | 4/43 (9.3) | 3/43 (7.0) | 1/43 (2.3) |
| Hyperuricemia | 1/43 (2.3) | 1/43 (2.3) | |
| Obesity | 14/43 (32.6) | 11/43 (25.6) | 3/43 (7.0) |
| Osteoporosis | 1/43 (2.3) | 1/43 (2.3) | |
| Polymyalgia rheumatica | 1/43 (2.3) | 1/43 (2.3) | |
| Pregnancy | 1/43 (2.3) | 1/43 (2.3) | |
| Rheumatoid arthritis | 1/43 (2.3) | 1/43 (2.3) | |
| Beta thalassemia trait | 1/43 (2.3) | 1/43 (2.3) | |
| Ankylosing spondylitis | 1/43 (2.3) | 1/43 (2.3) | |
| History of smoking or smoking | 4/43 (9.3) | 4/43 (9.3) |
CAPA: Coronavirus disease 2019-associated pulmonary aspergillosis, * classification of cases as CAPA or colonisation by Aspergillus according to the ECMM/ISHAM consensus criteria.